EU Price Transparency Directive Review Must Lead To ‘Concrete Outcomes’
Executive Summary
Industry figures hope that the European Commission’s review of the EU’s directive on the transparency of pricing and reimbursement processes will produce tangible outcomes that help get medicines to patients more quickly.